ARTICLE | Company News
PharmaMar sales and marketing update
May 9, 2016 7:00 AM UTC
The U.K.’s NICE issued final guidance recommending against the use of Yondelis trabectedin from PharmaMar to treat the first recurrence of platinum-sensitive ovarian cancer. The agency said that the ...